Short Interest in Oxbridge Re Holdings Limited (NASDAQ:OXBR) Decreases By 71.2%

Oxbridge Re Holdings Limited (NASDAQ:OXBR) was the target of a significant decline in short interest in December. As of December 15th, there was short interest totaling 6,218 shares, a decline of 71.2% from the November 30th total of 21,558 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average trading volume of 13,795 shares, the short-interest ratio is presently 0.5 days. Based on an average trading volume of 13,795 shares, the short-interest ratio is presently 0.5 days. Currently, 0.1% of the shares of the company are sold short.

Oxbridge Re Stock Down 0.8%

Shares of OXBR traded down $0.01 on Friday, reaching $1.20. The stock had a trading volume of 1,589 shares, compared to its average volume of 61,341. Oxbridge Re has a twelve month low of $1.12 and a twelve month high of $5.81. The firm has a market capitalization of $9.22 million, a PE ratio of -3.53 and a beta of 2.14. The firm has a 50-day moving average of $1.40 and a 200 day moving average of $1.76.

Oxbridge Re (NASDAQ:OXBR) last issued its quarterly earnings data on Thursday, November 6th. The insurance provider reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.01). The firm had revenue of $0.65 million for the quarter, compared to analyst estimates of $0.74 million. Oxbridge Re had a negative return on equity of 47.76% and a negative net margin of 109.74%.

Institutional Trading of Oxbridge Re

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Armistice Capital LLC purchased a new stake in Oxbridge Re during the 1st quarter worth about $1,176,000. J.W. Cole Advisors Inc. acquired a new stake in shares of Oxbridge Re during the 3rd quarter worth about $59,000. Finally, Virtu Financial LLC purchased a new stake in shares of Oxbridge Re during the third quarter worth about $32,000. 5.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Oxbridge Re in a report on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $5.00.

About Oxbridge Re

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.